Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kreus (Oulu, Finland), S. Lehtonen (Oulu, Finland), J. Salonen (Oulu, Finland), R. Hinttala (Oulu, Finland), R. Kaarteenaho (Oulu, Finland). NHLRC2 mRNA and protein expression in idiopathic pulmonary fibrosis. 3282

Member's Comments

No comment yet.

Related content which might interest you: PD-L1 expression in patients with idiopathic pulmonary fibrosis. Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Expression of mRNA of selected inflammatory markers in BALf cells from patients with sarcoidosis and idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 VEGF expression does not differentiate between idiopathic pulmonary fibrosis and pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 The expression of calgranulin B in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Expression of apoptotic markers in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 376s Year: 2003 IL-18 binding protein as a noble biomarker for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Expression of the Bcl-2 binding protein beclin 1 in human idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 MiRNA expression profile is altered upon cystic fibrosis pulmonary exacerbation Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Plasma protein signature of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 The global microRNA profile of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Aquoaporin-1 expression in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients Source: Eur Respir J 2014; 44: 802-805 Year: 2014 Pulmonary expression of alternatively spliced tissue factor as a potential prognostic marker in idiopathic pulmonary fibrosis Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Expression of redox-related selenoprotein P in lung tissues and fibroblasts obtained from the patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 825s Year: 2006 Differential expression of telomerase activity in patients with autoimmune pulmonary fibrosis in BALF Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 479s Year: 2002